Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cencora, Inc. Common Stock (NY:COR)

352.71 +22.74 (+6.89%)
Streaming Delayed Price Updated: 3:42 PM EST, Feb 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Cencora (COR) Stock Trades Up, Here Is Why
Shares of healthcare distributor Cencora (NYSE:COR) jumped 7.1% in the afternoon session after the company reported first-quarter results that beat profit expectations and raised its full-year... 
Via StockStory
Topics Artificial Intelligence
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts
Healthcare distributor Cencora (NYSE:COR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1%... 
Via StockStory
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Cencora Inc (NYSE:COR) Q1 2026 Earnings: Revenue Misses, EPS Beats, Shares Fall on Guidance ↗
Via Chartmill
News headline image
Cencora (COR) Q1 2026 Earnings Call Transcript ↗
Cencora (COR) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates
Healthcare distributor Cencora (NYSE:COR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1% above... 
Via StockStory
News headline image
Cencora Reports Fiscal 2026 First Quarter Results
From Cencora
Via Business Wire
News headline image
Cencora (COR) Reports Earnings Tomorrow: What To Expect
Healthcare distributor Cencora (NYSE:COR) will be reporting results this Wednesday before market open. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
News headline image
Cencora Elects Ellen Cooper to Its Board of Directors
From Cencora
Via Business Wire
News headline image
Healthcare Sector Stages Resilient Rebound as Policy Clarity and GLP-1 Innovations Fuel Investor Optimism
The U.S. healthcare sector has entered 2026 on a remarkably strong footing, staging a decisive rebound after a tumultuous 2025. This resurgence is being driven by a rare alignment of legislative... 
Via MarketMinute
Topics Earnings Economy
News headline image
3 Healthcare Stocks with Exciting Potential
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their... 
Via StockStory
Topics Stocks
News headline image
Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release
From Cencora
Via Business Wire
News headline image
2 Large-Cap Stocks Worth Your Attention and 1 We Question
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
Topics Credit Cards
News headline image
Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at health insurance providers stocks,... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR
CRANFORD, NJ — As the 2025 calendar year draws to a close, Citius Oncology, Inc. (Nasdaq: CTOR) has reached a pivotal juncture in its corporate evolution. Following the release of its SEC 10-K filing... 
Via MarketMinute
Topics Economy Regulatory Compliance
News headline image
2 Large-Cap Stocks Worth Investigating and 1 We Find Risky
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
News headline image
Medline’s Blockbuster IPO Ignites Market Optimism: The Largest Debut Since 2021
In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the... 
Via MarketMinute
Topics Economy Initial Public Offering World Trade
News headline image
Medline Industries (MDLN) Deep-Dive: The $54 Billion Return of a Healthcare Titan
The global healthcare landscape shifted decisively on December 16, 2025, with the public market return of Medline Industries (Nasdaq: MDLN). After four years under the stewardship of a private equity... 
Via PredictStreet
Topics Artificial Intelligence Earnings Economy
News headline image
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
From Cencora
Via Business Wire
News headline image
Digital Gold Rush: AI Fuels Unprecedented Data Center Boom, Reshaping Global Economy
The global economy is witnessing a transformative surge in data center investment and growth, propelled primarily by the insatiable demands of Artificial Intelligence (AI), the ever-expanding reach of... 
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
News headline image
1 S&P 500 Stock to Own for Decades and 2 That Underwhelm
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
Why Cencora (COR) Shares Are Trading Lower Today
Shares of healthcare distributor Cencora (NYSE:COR) fell 4.3% in the afternoon session after analysts downgraded the company's stock to a "hold" rating from a "buy" a few days prior. This downgrade... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Stay updated with the movements of the S&P500 index in the middle of the day on Wednesday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
News headline image
1 Healthcare Stock to Own for Decades and 2 We Avoid
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
News headline image
If You Invested $100 In Cencora Stock 5 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
The 5 Most Interesting Analyst Questions From Cencora’s Q3 Earnings Call
Cencora’s third quarter saw a positive market response, as the company delivered revenue and non-GAAP earnings that exceeded Wall Street expectations. Management pointed to strong growth in its U.S.... 
Via StockStory
Topics Earnings
News headline image
COR Q3 Deep Dive: Specialty Expansion and Portfolio Restructuring Drive Strategic Focus
Healthcare distributor Cencora (NYSE:COR) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.9% year on year to $83.73 billion. Its non-GAAP profit of $3.84 per share... 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.